Connect with Inverna Therapeutics at BIO-Europe November 9–11, 2026 Cologne, Germany
Inverna Therapeutics is pleased to announce its participation at BIO-Europe…
Unlocking precision RNA therapeutics
Inverna Therapeutics is dedicated to the development of an RNA therapeutics platform to modify RNA expression with unparalleled specificity. Leveraging sequence-specific activation of pseudo exons, we develop safer, more effective precision medicines for unmet medical needs.
Transforming RNA discovery into therapy
Inverna is pioneering RNA therapeutics with its proprietary pseudo-exon activation platform. By precisely modulating splicing, we control how genes are expressed, ultimately adjusting the expression of specific proteins to target disease at its source.
Our programs
We are advancing precision RNA splicing modulation therapies for neurodegenerative diseases, with lead programs focusing on Parkinson’s disease and Huntington’s disease.
Meet the team advancing RNA therapeutics
Behind Inverna is a team of scientists, innovators, and industry leaders dedicated to turning cutting-edge RNA research into real-world therapies.
Latest news
Inverna Therapeutics will be speaking to potential investors and collaboration partners at BioFIT on December 10th & 11th 2026
Inverna Therapeutics will attend BioFIT 2026 in Marseille. CEO Poul…
Meet up with Inverna Therapeutics at the TIDES Europe 2026 in Amsterdam, November 2026
Meet Inverna Therapeutics at TIDES Europe 2026, November 3–5 in…